Literature DB >> 19842387

The prevalence of sexually transmitted and other lower reproductive tract infections among rural women in Sichuan Province, China.

Tang Yongjun1, Julia Samuelson, Dong Qingsheng, Mohamed Mahmoud Ali, Xie Li, Meng Yanjian, Cheng Xiaoqing, Lan Jun, Cheng Jian, Luo Bi.   

Abstract

To estimate the prevalence of sexually transmitted infections (STI) and lower reproductive tract infections (RTI) and determine risk factors for STI among rural women in Sichuan Province, China, a cross-sectional, community-based cluster sample of 2,000 rural, married women were interviewed, examined and clinical specimens collected to assess for six STI and two non-sexually transmitted RTI. The overall prevalence of any STI was 10.9% (95% CI 9.5-12.3); of any STI or RTI was 30.8% (95% CI 28.7-32.8). Chlamydia trachomatis was detected in 6.4% of women, Neisseria gonorrhoeae in 1.7%, Treponema pallidum in 0.5%, human papilloma virus in 0.6%, herpes simplex virus type-2 in 2.0%, Candida albicans in 8.8%, Trichomonas vaginalis in 0.7% and bacterial vaginosis in 15.4%. The reported low risk sexual behavior was corroborated by the prevalence of STIbased on laboratory findings. The prevalence of Chlamydia trachomatis alone and the combined prevalence rates of Neisseria gonorrhoeae and Chlamydia trachomatis were high enough (7.9%) to consider interventions for the control of cervical infections. Health promotion messages regarding safe sexual and health care seeking behavior is important. Routine STI surveillance, including prevalence studies, which provide accurate information for decision-making should be continued as an essential component of good STI control.

Entities:  

Mesh:

Year:  2009        PMID: 19842387

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  7 in total

1.  Gynecologic infections seen in ThinPrep cytological test in Wuhan, China.

Authors:  Hang Zhou; Yao Jia; Jian Shen; Shaoshuai Wang; Xiong Li; Ru Yang; Kecheng Huang; Ting Hu; Fangxu Tang; Jin Zhou; Jingping Yuan; Lei Huang; Xun Tian; Zhilan Chen; Qinghua Zhang; Changyu Wang; Ling Xi; Dongrui Deng; Hui Wang; Ding Ma; Shuang Li
Journal:  Front Med       Date:  2014-03-20       Impact factor: 4.592

2.  Role of Chlamydia trachomatis and emerging Chlamydia-related bacteria in ectopic pregnancy in Vietnam.

Authors:  S Hornung; B C Thuong; J Gyger; C Kebbi-Beghdadi; S Vasilevsky; G Greub; D Baud
Journal:  Epidemiol Infect       Date:  2014-12-29       Impact factor: 4.434

Review 3.  Probiotics for the Treatment of Bacterial Vaginosis: A Meta-Analysis.

Authors:  Ziyue Wang; Yining He; Yingjie Zheng
Journal:  Int J Environ Res Public Health       Date:  2019-10-12       Impact factor: 3.390

4.  Vulvovaginitis Prevalence Among Women in Gondar, Northwest Ethiopia: Special Emphasis on Aerobic Vaginitis Causing Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Factors.

Authors:  Jemal Yasin; Getnet Ayalew; Mulat Dagnaw; Getachew Shiferaw; Feleke Mekonnen
Journal:  Infect Drug Resist       Date:  2021-11-02       Impact factor: 4.003

5.  Prevalence of reproductive tract infections among women preparing to conceive in Chongqing, China: trends and risk factors.

Authors:  Jun Liu; Mengyao Zeng; Liu Yang; Yanyan Mao; Yang He; Min Li; Qing Chen; Weijin Zhou; Liang Chen; Qianxi Zhu
Journal:  Reprod Health       Date:  2022-10-03       Impact factor: 3.355

6.  Low prevalence of Chlamydia trachomatis infection in non-urban pregnant women in Vellore, S. India.

Authors:  Navjyot K Vidwan; Annie Regi; Mark Steinhoff; Jill S Huppert; Mary Allen Staat; Caitlin Dodd; Rida Nongrum; Shalini Anandan; Valsan Verghese
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

7.  Prevalence of Chlamydia trachomatis infection in the general population of women in Qatar.

Authors:  Asma Al-Thani; Hanan Abdul-Rahim; Enas Alabsi; Haneen N Bsaisu; Pascale Haddad; Ghina R Mumtaz; Laith J Abu-Raddad
Journal:  Sex Transm Infect       Date:  2013-07-17       Impact factor: 3.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.